Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Magnesium sulfate added to a 3-drug intravenous regimen for acute migraine attacks
IRCT20240930063211N1Phase 3Completed
- Sponsor
- Ahvaz Jundishapur University of Medical Sciences
- Start
- Sep 2024
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of magnesium sulfate in migraine (2 arms), sponsored by Ahvaz Jundishapur University of Medical Sciences. Primary endpoint: pain. Started Sep 2024; status: completed.
02
Drugs
magnesium sulfate
03
Conditions
migraine
Beyond the preview
Go deeper on IRCT20240930063211N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20240930063211N1.